Cargando...
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
AIMS: To examine 12-month outcomes of eyes switching from intravitreal ranibizumab to aflibercept for neovascular age-related macular degeneration (nAMD). METHODS: Database observational study of eyes with nAMD tracked by the Fight Retinal Blindness outcome registry that received ranibizumab for at...
Guardado en:
| Publicado en: | Br J Ophthalmol |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5256411/ https://ncbi.nlm.nih.gov/pubmed/26994110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2015-308090 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|